Scotts Miracle-Gro (SMG) Tops Q2 EPS by 4c; offers outlook

Scotts Miracle-Gro (NYSE: SMG) reported Q2 EPS of $3.98, $0.04 better than the analyst estimate of $3.94. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.5 billion.

Fiscal 2025 Outlook

The Company reaffirms its previously announced U.S. Consumer segment net sales, adjusted gross margin, adjusted EBITDA and free cash flow guidance. Given the continued uncertain environment in the cannabis industry, the Company is no longer providing full-year revenue guidance for its Hawthorne segment. More details will be shared during today’s call, and the Company also expects to provide an updated outlook in early June.

For earnings history and earnings-related data on Scotts Miracle-Gro (SMG) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• 37 Capital raises $300,000 in partial private placement closing
• BetterLife Pharma files final prospectus for $100M public offering